November 3, 2008 - ACIST Medical Systems Inc. (a Bracco Group company), signed a distribution agreement for the StatSensor Creatinine Meter with Nova Biomedical, in which the ACIST and Nova teams will co-exclusively market and distribute the StatSensor Creatinine Meter into the medical fields of radiology and cardiology within North America.
Toshiba's Infinix-i floor mounted, 5-axis system is a cardiovascular lab featuring patient access and coverage, making ...
November 3, 2008 - CardioNet Inc. a wireless medical technology company with a focus on the diagnosis and monitoring of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 3, 2008 - LifeNet Health received 510(k) clearance from the FDA for CardioGraft allograft cardiac patch ...
November 3, 2008 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, and Covidien have entered into a co-marketing agreement to offer a combined portfolio of high-energy and low-energy radioisotopes to the nuclear medicine community in the U.S.
A new ultrasound system for radiology and vascular applications, the LOGIQ E9, fuses ultrasound images with images from other imaging modalities like CT and MR.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Stereotaxis Inc. said the FDA cleared its magnetically tipped PowerAssert radiofrequency (RF) guide wire to cross chronic total occlusions (CTOs) in the peripheral vasculature.
Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) specifically designed for treating small coronary vessels. The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, Boston Scientific said. The Taxus Express 2 Atom received FDA approval in the fall of 2008.
October 31, 2008 - Corgenix Medical Corp. recently said new CHARISMA trial findings published in Circulation confirm ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Cardiovascular care does not occur in a single hospital setting; more often than not patients undergo a variety of tests at different locations. In order to provide the best care possible, physicians need immediate access to all patient information, no matter where, when or how it was obtained.
St. Jude Medical said the FDA cleared its SJM Confirm implantable cardiac monitor (ICM), a compact device designed to help physicians diagnose abnormal heart rhythms.
Concentric Medical’s V series of Merci Retrievers is available in multiple configurations and sizes to match patient anatomy to remove blood clots and help restore blood flow in patients who have suffered ischemic strokes.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The ClariTEE miniaturized transesophageal echocardiography probe facilitates episodic monitoring of cardiac function. It is a single-use device that can remain indwelling for up to 72 hours, allowing intensivists and anesthesiologists to periodically assess cardiac preload and left ventricular systolic function over a prolonged period of time.
The Piccolo Xpress is designed to enable cardiologists to quickly run CLIA-waived Creatinine and BUN tests via the ...
Micrus Endovascular Corp. launched the Cerecyte and stretch-resistant versions of its DeltaPaq microcoil system for the treatment of cerebral aneurysms.
November 02, 2008
